A Randomized, Double‐Blind, Placebo‐Controlled, Sixteen‐Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis

OBJECTIVE: Axial spondyloarthritis (SpA) is a chronic inflammatory disease characterized by back pain and stiffness. The objective of this study was to determine whether golimumab is superior to placebo in patients with nonradiographic axial SpA. METHODS: This phase III, double‐blind, randomized, pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sieper, J., van der Heijde, D., Dougados, M., Maksymowych, W. P., Scott, B. B., Boice, J. A., Berd, Y., Bergman, G., Curtis, S., Tzontcheva, A., Huyck, S., Weng, H. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Spondyloarthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755041/
https://www.ncbi.nlm.nih.gov/pubmed/26139307
http://dx.doi.org/10.1002/art.39257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755041/
https://www.ncbi.nlm.nih.gov/pubmed/26139307
http://dx.doi.org/10.1002/art.39257

Ejemplares similares